Clin2
NCT07705464Possibly a fitNot yet recruiting

Stem cell therapy for frailty in older adults

Frailty

This study tests a new stem cell medicine given through an IV to see if it is safe for older adults with mild to moderate frailty. Frailty causes weakness and tiredness, and this treatment aims to improve overall health and function.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
12 people
Ages
60 years to 85 years
Study type
Interventional

Who can take part

  • You must be between 60 and 85 years old.
  • You must have been diagnosed with mild to moderate frailty.
  • Your weight must be between 40 and 90 kg (about 88 to 198 pounds).
  • You cannot have serious health issues like severe heart, lung, kidney, or liver disease, or certain neurological conditions (like Parkinson's or dementia).
  • You cannot have had cancer in the last 5 years (except for very minor skin cancers).
  • You must not be on immune-suppressing drugs or blood thinners, or be willing to have them adjusted with the study doctor's approval.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06070532Not yet recruiting· Phase 1/Phase 2
Investigational cell therapy for frailty in older adults

This study tests an investigational treatment made from special cells (called mesenchymal stromal cells) that might help reduce frailty in older adults. The treatment is given through an IV and aims to improve strength and overall function.

Nassau
NCT05018767Recruiting· Phase 1
Testing an IV stem cell treatment for aging frailty safety

This early study (Phase 1) tests whether a lab-made stem cell product given through an IV is safe in people with “aging frailty.” It looks mainly at side effects and safety while also exploring whether the treatment can be given safely.

St John's
NCT06099912Recruiting
Personalized frailty-based treatment for older adults with new multiple myeloma

This trial tests a personalized treatment approach for people aged 65 and older with newly diagnosed multiple myeloma. The goal is to tailor therapy based on each patient's level of frailty, which could help improve outcomes and reduce side effects.

Changchun, Jilin
NCT03458429Enrolling by invitation· Phase 1/Phase 2
Plasma from healthy donors for frailty and immune health

This Phase 1/2 study tests whether transfusions of donated plasma can improve frailty and immune function in older adults. It mainly checks safety first, and also looks for signs that the immune system and overall strength may improve.

Boynton Beach, Florida
NCT07132632Not yet recruiting
Exercise program for frailty in older adults

This trial tests a special exercise program designed for older adults who are frail or have muscle loss. The goal is to help improve strength and daily function, and participating may help you stay independent longer.

NCT05002439Recruiting
Exercise program to reduce frailty in older adults

This trial tests whether a Spanish health-clinic–guided exercise program can improve frailty in people who are starting to become frail (“pre-frail”). It may help you build strength and walking ability through supervised physical activity.

Albacete

Hear when a new Frailty trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.